Abstract
A semiquantitative assay of DNA impurities in preparations of human recombinant insulin is described. The assay is based on the detection of a fragment of the ampicillin-resistant gene within the producer strain DNA by PCR. The analysis of PCR products of the studied preparations and PCR products containing known amounts of E. coli total DNA enabled a quantitative determination of the producer strain DNA content in the preparations under study. The sensitivity of the method is 7 pg of E. coli DNA per 10µg of human recombinant insulin. The high sensitivity of the method allows us to recommend it for the quantitative determination of DNA content in recombinant preparations that do not inhibit PCR.
Similar content being viewed by others
REFERENCES
Farmakopeinaya stat’ya predpriyatiya Institut bioorganicheskoi khimii im. M. M. Shemyakina i Yu.A. Ovchinnikova RAN (Pharmacopoeia Monograph of the Enterprise Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS) FSP42-0452361302. Human insulin, 2002, Moscow.
Haugland, R.P and Kang, H.C, Chemically Reactive Dipyrrometheneboron Difluoride Dyes, US Patent 4774339.
Matz, M.V., in Methods Mol. Biol., Hicks, B.W, Ed., Totowa: Humana, 2003, vol. 221, pp. 103–116.
Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, NY: Cold Spring Harbor Lab., 1989.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Bioorganicheskaya Khimiya, Vol. 31, No. 1, 2005, pp. 73–76.
Original Russian Text Copyright © 2005 by Aleksandrov, Yu. Skoblov, M. Skoblov, Shibanova, Bairamashvili, Miroshnikov.
Rights and permissions
About this article
Cite this article
Aleksandrov, A.N., Skoblov, Y.S., Skoblov, M.Y. et al. A PCR-based semiquantitative assay of DNA impurities in recombinant protein preparations. Russ J Bioorg Chem 31, 66–69 (2005). https://doi.org/10.1007/s11171-005-0008-6
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s11171-005-0008-6